Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-007520
Filing Date
2022-07-06
Accepted
2022-07-06 18:03:48
Documents
2
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 form4-07062022_030739.html 4  
1 form4-07062022_030739.xml 4 3530
2 ex24-07062022_030740.htm EX-24 6767
  Complete submission text file 0001415889-22-007520.txt   11624
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Issuer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address
Correia de Simas Jose Manuel (Reporting) CIK: 0001809748 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 221069996